Avoro Capital Advisors LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$3.0T
Holdings
41
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (41 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —IMMUNOMEDICS INC | 24,500,000 | $330.3B | 11.15% | |
| 2 | MRTXEURMIRATI THERAPEUTICS INC | 4,112,700 | $316.1B | 10.67% | |
| 3 | IOVAIOVANCE BIOTHERAPEUTICS INC | 10,260,413 | $272.9B | 9.21% | Call |
| 4 | ASNDASCENDIS PHARMA | 1,787,000 | $201.2B | 6.79% | |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,930,000 | $163.1B | 5.50% | |
| 6 | SRPTSAREPTA THERAPEUTICS INC | 1,585,000 | $155.0B | 5.23% | |
| 7 | HZNPHORIZON THERAPEUTICS PLC | 4,575,000 | $135.5B | 4.57% | |
| 8 | KPTIEURKARYOPHARM THERAPEUTICS INC | 7,000,000 | $134.5B | 4.54% | |
| 9 | ARGXARGENX SE | 936,500 | $123.4B | 4.16% | |
| 10 | —CONSTELLATION PHARMACEUTICALS INC | 3,650,000 | $114.7B | 3.87% | |
| 11 | AM6AMICUS THERAPEUTICS INC | 10,950,000 | $101.2B | 3.42% | |
| 12 | DCPHEURDECIPHERA PHARMACEUTICALS INC | 2,000,000 | $82.3B | 2.78% | |
| 13 | QUREUNIQURE NV | 1,650,000 | $78.3B | 2.64% | |
| 14 | XLRNACCELERON PHARMA INC | 860,000 | $77.3B | 2.61% | |
| 15 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 7,150,000 | $69.9B | 2.36% | |
| 16 | —ZOGENIX INC | 2,800,000 | $69.2B | 2.34% | |
| 17 | —MYOKARDIA INC | 1,435,000 | $67.3B | 2.27% | |
| 18 | PTCTPTC THERAPEUTICS INC | 1,200,000 | $53.5B | 1.81% | |
| 19 | RLMDRELMADA THERAPEUTICS INC | 1,150,000 | $39.2B | 1.32% | |
| 20 | ATNXEURATHENEX INC | 4,875,000 | $37.7B | 1.27% | |
| 21 | AVDLAVADEL PHARMACEUTICALS PLC | 4,365,655 | $34.7B | 1.17% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 2,772,000 | $31.4B | 1.06% | |
| 23 | 1T7TRICIDA INC | 1,365,000 | $30.0B | 1.01% | |
| 24 | SG7SAGE THERAPEUTICS INC | 1,000,000 | $28.7B | 0.97% | |
| 25 | CUECUE BIOPHARMA INC | 1,870,000 | $26.5B | 0.90% | |
| 26 | AUPHAURINIA PHARMACEUTICALS INC | 1,725,000 | $25.0B | 0.84% | |
| 27 | MDGLMADRIGAL PHARMACEUTICALS INC | 349,000 | $23.3B | 0.79% | |
| 28 | ALLOALLOGENE THERAPEUTICS INC | 1,128,594 | $21.9B | 0.74% | |
| 29 | TREURTRILLIUM THERAPEUTICS INC | 4,950,000 | $20.0B | 0.68% | |
| 30 | BDTXBLACK DIAMOND THERAPEUTICS INC | 521,750 | $13.0B | 0.44% | |
| 31 | —MARINUS PHARMACEUTICALS INC | 6,200,000 | $12.6B | 0.42% | |
| 32 | —BIODELIVERY SCIENCES INTL | 3,000,000 | $11.4B | 0.38% | |
| 33 | RVMDREVOLUTION MEDICINES INC | 450,000 | $9.9B | 0.33% | |
| 34 | CBAYUSDCYMABAY THERAPEUTICS INC | 5,500,000 | $8.1B | 0.27% | |
| 35 | AMRNAMARIN CORP PLC | 3,000,000 | $8.0B | 0.27% | Call |
| 36 | TGTXTG THERAPEUTICS INC | 800,000 | $7.9B | 0.27% | |
| 37 | AGENEURAGENUS INC | 2,750,000 | $6.7B | 0.23% | |
| 38 | FRXFENNEC PHARMACEUTICALS INC | 1,105,999 | $6.6B | 0.22% | |
| 39 | IMGNEURIMMUNOGEN INC | 1,900,000 | $6.5B | 0.22% | |
| 40 | ACADACADIA PHARMACEUTICALS INC | 145,000 | $6.1B | 0.21% | |
| 41 | —ALIMERA SCIENCES INC | 415,999 | $1.6B | 0.05% |